First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 3.1 USD 1.31% Market Closed
Updated: May 29, 2024

Aquestive Therapeutics Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aquestive Therapeutics Inc
Accumulated Depreciation Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Accumulated Depreciation
-$43m
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Accumulated Depreciation
-$28B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Bristol-Myers Squibb Co
NYSE:BMY
Accumulated Depreciation
-$4.9B
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
-1%
Pfizer Inc
NYSE:PFE
Accumulated Depreciation
-$16.4B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Accumulated Depreciation
-$18.6B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Accumulated Depreciation
-$11.2B
CAGR 3-Years
-5%
CAGR 5-Years
-5%
CAGR 10-Years
-4%

See Also

What is Aquestive Therapeutics Inc's Accumulated Depreciation?
Accumulated Depreciation
-43m USD

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Accumulated Depreciation amounts to -43m USD.

What is Aquestive Therapeutics Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-4%

Over the last year, the Accumulated Depreciation growth was -2%. The average annual Accumulated Depreciation growth rates for Aquestive Therapeutics Inc have been -4% over the past three years , -4% over the past five years .